Sex behavior of male and female Wistar rats affected by the serotonin agonist 8-OH-DPAT.

Pharmacol Biochem Behav

Department of Endocrinology and Reproduction, Faculty of Medicine and Health Sciences Erasmus University, Rotterdam, The Netherlands.

Published: October 1991

Four experiments were carried out to test the stimulatory effects of 8-OH-DPAT on various aspects of "masculine" sexual behavior of male and female rats and on the sexual attractivity of male rats. In Experiment 1 8-OH-DPAT (0.2 mg/kg) stimulated ejaculation frequency in middle-aged (approx. 15 months old) males, both sexually inactive and active subjects. There was a coinciding decrease in total number of mounts, intromissions, intromissions to first ejaculation and latency to first ejaculation. In Experiment 2 the effects of two doses (0.2 and 0.4 mg/kg) 8-OH-DPAT on the first ejaculation cycle were investigated. Especially, the higher dose made a high percentage (45-55%) of males to ejaculate "prematurely," i.e., at the first or second intromission. Latency to ejaculation decreased. With the higher dose, 25-35% of the males ejaculated extravaginally. In Experiment 3 8-OH-DPAT did not make males more attractive for an estrous female than saline-treated males, as judged by the time spent in their vicinity. However, estrous females received much more ejaculations from the tethered 8-OH-DPAT males, with the lowest latencies to first ejaculation, than from the saline-treated males. In Experiment 4 8-OH-DPAT stimulated mounting behavior in female rats only when they were long-term treated with testosterone. In that condition also shortest latencies to first mount were found with 8-OH-DPAT treatment.

Download full-text PDF

Source
http://dx.doi.org/10.1016/0091-3057(91)90543-bDOI Listing

Publication Analysis

Top Keywords

experiment 8-oh-dpat
12
behavior male
8
male female
8
8-oh-dpat
8
female rats
8
latency ejaculation
8
higher dose
8
8-oh-dpat males
8
saline-treated males
8
males
7

Similar Publications

Like other brain circuits, the brainstem respiratory network is continually modulated by neurotransmitters that activate slow metabotropic receptors. In many cases, activation of these receptors only subtly modulates the respiratory motor pattern. However, activation of some receptor types evokes the arrest of the respiratory motor pattern as can occur following the activation of μ-opioid receptors.

View Article and Find Full Text PDF

The heterogeneity of etiology may serve as a crucial factor in the challenges of treatment, including the low response rate and the delay in establishing therapeutic effect. In the present study, we examined whether social experience since early life is one of the etiologies, with the involvement of the 5-HT1A receptors, and explored the potentially therapeutic action of the subchronic administration of buspirone, a partial 5-HT1A agonist. Rats were isolation reared (IR) since their weaning, and the depressive profile indexed by the forced-swim test (FST) was examined in adulthood.

View Article and Find Full Text PDF

Evaluation of multitarget drugs on the expression of cocaine-induced locomotor sensitization in male rats: A comparative study.

Heliyon

May 2024

Subdirección de Investigaciones Clínicas. Laboratorio de Neurofarmacología Conductual, Microcirugía y Terapéutica Experimental. Instituto Nacional de Psiquiatría. Ciudad de México, 14370, Mexico.

Purpose: - Cocaine use disorder (CUD) is a complex disease. Several studies have shown the efficacy of multitarget drugs used to treat CUD. Here we compare the efficacy of mirtazapine (MIR), pindolol (PIN), fluoxetine (FLX), risperidone (RIS), trazodone (TRZ), ziprasidone (ZPR), ondansetron (OND), yohimbine (YOH), or prazosin (PRZ), to reduce long-term cocaine-induced locomotor activity and the expression of cocaine-induced locomotor sensitization in rats.

View Article and Find Full Text PDF

Comparative Pharmacological Effects of Lisuride and Lysergic Acid Diethylamide Revisited.

ACS Pharmacol Transl Sci

March 2024

Designer Drug Research Unit, National Institute on Drug Abuse, Intramural Research Program, Baltimore, Maryland 21224, United States.

Lisuride is a non-psychedelic serotonin (5-HT) 2A receptor (5-HT) agonist and analogue of the psychedelic lysergic acid diethylamide (LSD). Lisuride also acts as an agonist at the serotonin 1A receptor (5-HT), a property known to counter psychedelic effects. Here, we tested whether lisuride lacks psychedelic activity due to a dual mechanism: (1) partial agonism at 5-HT and (2) potent agonism at 5-HT.

View Article and Find Full Text PDF

Serotonin therapies for opioid-induced disordered swallow and respiratory depression.

J Appl Physiol (1985)

April 2024

Department of Speech, Language, and Hearing Sciences and Dalton Cardiovascular Center, University of Missouri, Columbia, Missouri, United States.

Opioids are well-known to cause respiratory depression, but despite clinical evidence of dysphagia, the effects of opioids on swallow excitability and motor pattern are unknown. We tested the effects of the clinically relevant opioid buprenorphine on pharyngeal swallow and respiratory drive in male and female rats. We also evaluated the utility of 5-HT agonists (8-OH-DPAT and buspirone) to improve swallowing and breathing following buprenorphine administration.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!